CommentFunding for practice-oriented clinical research
References (20)
Health research in the UK: the price of success
Lancet
(2006)- et al.
Effect of a US National Institutes of Health programme of clinical trials on public health and costs
Lancet
(2006) Excellence, can we be equal and excellent too?
(1995)UK health research analysis: the first national analysis of health research in the UK
- et al.
descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980–2002
BMJ
(2003) Medical academia is failing patients and clinicians: the neglect of basic observational clinical research
BMJ
(2006)The fundamentals of clinical discovery
Perspect Biol Med
(2004)Strengthening clinical research
Effectiveness and efficiency: random reflections on health services
(1972)Parkinson's disease: national clinical guideline for diagnosis and management in primary and secondary care
There are more references available in the full text version of this article.
Cited by (35)
20 years of improvement in stroke care: the rewards from finally funding more research
2022, The Lancet NeurologyClinical innovation in stroke: getting the simple things right
2018, The Lancet NeurologyAVERT: A major milestone in stroke research
2015, The LancetPotentials for research and innovations in allied health professions in Germany
2014, Zeitschrift fur Evidenz, Fortbildung und Qualitat im GesundheitswesenIncreasing value and reducing waste in biomedical research regulation and management
2014, The LancetCitation Excerpt :Extended application of this policy would help to achieve greater integration of research within routine care. Inevitably, prioritisation of practice-oriented clinical research requires further shifts in the distribution of research funds.96 There are opportunity costs of wasteful regulation and management of research.
How to increase value and reduce waste when research priorities are set
2014, The LancetCitation Excerpt :Global investment in biomedical research is increasing, reaching US$240 billion (adjusted for purchasing power parity) in 2010.5 Basic research is the principal beneficiary of this investment.6 More than half of the £1·6 billion in public and charitable investment in research in the UK in 2009–10 was allocated to basic research (table 1),7 a pattern that was also reported in the USA in 2012.8
Copyright © 2006 Elsevier Ltd. All rights reserved.